1. Home
  2. AVAV vs GRFS Comparison

AVAV vs GRFS Comparison

Compare AVAV & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVAV
  • GRFS
  • Stock Information
  • Founded
  • AVAV 1971
  • GRFS 1940
  • Country
  • AVAV United States
  • GRFS Spain
  • Employees
  • AVAV N/A
  • GRFS N/A
  • Industry
  • AVAV Aerospace
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVAV Industrials
  • GRFS Health Care
  • Exchange
  • AVAV Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • AVAV 7.4B
  • GRFS 6.2B
  • IPO Year
  • AVAV 2007
  • GRFS 2006
  • Fundamental
  • Price
  • AVAV $265.00
  • GRFS $9.77
  • Analyst Decision
  • AVAV Strong Buy
  • GRFS Hold
  • Analyst Count
  • AVAV 9
  • GRFS 1
  • Target Price
  • AVAV $265.22
  • GRFS $10.30
  • AVG Volume (30 Days)
  • AVAV 2.4M
  • GRFS 817.6K
  • Earning Date
  • AVAV 09-03-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • AVAV N/A
  • GRFS N/A
  • EPS Growth
  • AVAV N/A
  • GRFS N/A
  • EPS
  • AVAV 1.55
  • GRFS 0.31
  • Revenue
  • AVAV $820,627,000.00
  • GRFS $7,968,532,207.00
  • Revenue This Year
  • AVAV $149.20
  • GRFS $7.14
  • Revenue Next Year
  • AVAV $15.45
  • GRFS $7.16
  • P/E Ratio
  • AVAV $171.15
  • GRFS $39.34
  • Revenue Growth
  • AVAV 14.50
  • GRFS 10.76
  • 52 Week Low
  • AVAV $102.25
  • GRFS $6.19
  • 52 Week High
  • AVAV $295.90
  • GRFS $9.96
  • Technical
  • Relative Strength Index (RSI)
  • AVAV 69.13
  • GRFS 71.66
  • Support Level
  • AVAV $228.89
  • GRFS $8.84
  • Resistance Level
  • AVAV $295.90
  • GRFS $9.91
  • Average True Range (ATR)
  • AVAV 15.01
  • GRFS 0.20
  • MACD
  • AVAV -0.04
  • GRFS 0.07
  • Stochastic Oscillator
  • AVAV 71.39
  • GRFS 92.52

About AVAV AeroVironment Inc.

AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: